Profusa, Inc. (PFSA)
NASDAQ: PFSA · Real-Time Price · USD
2.270
+0.580 (34.32%)
At close: Sep 29, 2026, 4:00 PM EDT
2.130
-0.140 (-6.15%)
After-hours: Sep 29, 2026, 7:45 PM EDT
Profusa Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
1.37M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 100.00K | 55.00K | 122.22% |
| Dec 31, 2023 | 45.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 742.00K | -3.20M | -81.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 20.90M |
| Nuwellis | 9.01M |
| Beyond Air | 7.69M |
| Tenon Medical | 5.31M |
| VolitionRx | 2.46M |
| Catheter Precision | 1.92M |
| Nexalin Technology | 217.16K |
| Adagio Medical Holdings | 137.00K |
PFSA News
- 5 days ago - Why Is Penny Stock Profusa (PFSA) Up Today? - TipRanks
- 5 days ago - Profusa announces progress towards Lumee oxygen platform CE mark - TheFly
- 5 days ago - Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October - GlobeNewsWire
- 14 days ago - Profusa regains Nasdaq compliance - TheFly
- 14 days ago - Profusa, Inc. Receives Nasdaq Compliance Determination - GlobeNewsWire
- 4 weeks ago - Profusa regains compliance with Nasdaq - TheFly
- 4 weeks ago - Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement - GlobeNewsWire
- 5 weeks ago - Profusa Inc trading resumes - TheFly